毛萼香茶菜中的新二萜化合物——毛萼晶P

从毛萼香茶菜的叶的甲醇提取物中分离得到两个二萜化合物,ｃｏｅｔｓｏｉｄｉｎＡ和毛萼晶Ｐ,它是目前从香茶菜属分离到的仅有的两个Ｂ环具有α,β－不饱和酮结构的对映－贝壳杉烷型二萜事物,其中毛萼晶Ｐ为新化合物     

疏花毛萼香茶菜中一新的对映-贝壳杉烷型二萜

从疏花毛萼香茶菜（Ｉｓｏｄｏｎ ｅｒｉｏｃａｌｙｘ ｖａｒ．ｌａｘｉｆｌｏｒａ）叶中分离得到一新的对映－贝壳杉烷型二萜,命名为疏花丁素（１）,通过波谱方法鉴定了它的结构。此外,还分离得到６个已知对映－贝壳杉烷型二萜化合物：疏花甲素（２）,毛萼晶Ａ－Ｃ（３－５）和Ｑ（６）,毛萼乙素（７）,以及ｃｉｒｓｉｍａｒｉｔｉｎ（８）和２α－羟基乌索酸（９）。     

黔产毛萼香茶菜二萜成分

综合利用硅胶、凝胶、MCI等柱层析方法从毛萼香茶菜中进行分离、纯化到10个二萜化合物,结合MS、1H NMR、13C NMR和相关文献资料分别鉴定为6-乙酰基-毛萼晶B(1)、毛萼晶O(2)、12-hydroxydehydro-abietic acid(3)、Neorabdosin(4)、毛萼晶D(5)、毛萼晶E(6)、毛萼晶B(7)、毛萼晶N(8)、Coetsoidin A(9)、毛萼晶L(10)。其中化合物1为新天然产物,3为首次从该植物中分离。     

疏花毛萼香茶菜的二萜成分

从疏花毛萼香茶菜叶的乙醚提取物中一共分得七个二萜化合物,其中四个经各项光谱数据证明它们分别为毛萼乙素(1),毛萼晶甲(2),毛萼晶乙(3)和冬凌草素(4)。     

毛萼香茶菜的新二萜化合物,毛萼晶甲-戊的结构

香茶菜属(Rabdosia)植物中的二萜化合物具有多种生理活性,如抗肿瘤,抗菌,抑制线粒体的吸呼作用和昆虫的生长等。在我们研究该属植物生理活性成分的课题中,我们从云南省丽江县蟠龙公社金沙江河谷地区产毛萼香茶菜〔Rabdosia eriocalyx(Dunn)Hara〕叶的乙醇提取物中分得七个结晶化合物,其中五个为新化合物,命名为毛萼晶甲一戊(maoecrystal A-E),另外两个为已知化合物毛萼甲素(eriocalyxinA)和乙素(eriocalyxin B)。     

毛萼香茶菜的新二萜成份(一)

毛萼香茶菜〔Rabdosia eriocalyx(Dunn)Hara〕系唇形科香茶菜属植物,产云南,四川西部,贵州南部,广西西部;生于山坡阳处灌丛中,海拔750—2600米,俗名大马鞭梢,烂脚丫巴草。民间用叶茎煨服退热,叶治香港脚,根止泻止痢,其成份研究尚未见报道。为了寻找新的抗癌活性成份,我们从其叶的乙醚提取物中分到四个单体,定名为毛萼甲、乙、丙和丁素(eriocalyxin A,B,C and D),根据光谱和化学证据,毛萼甲素和乙素这两个新二萜成份的结构分别确定为Ⅰ式和Ⅱ式。     

毛萼香茶菜二萜化合物的高效液相色谱定量分析

本文报道用HPLC分离测定毛萼香茶菜(Rabdosia eriocalyx)中的二萜化合物。总二萜提取物在zorbax ODS柱上,用甲醇-水(70:30)作流动相,毛萼晶乙、毛萼晶丙等五个化合物在18分钟内能很好分离。以odonicin为内标,用峰面积比测定各组份的含量。结果符合一般含量测定的要求,此法可作为香茶菜二萜化合物一类生物活性物质的分析及发现新二萜化合物的前导性有效筛选手段。     

毛萼香茶菜中的一个新二萜

从毛萼香茶菜中分得8个二萜,3-乙酰毛萼结晶S、毛萼结晶甲、毛萼结晶乙、毛萼结晶丙、毛萼结晶丁、trichrokaurin、edonicin和eriocalyxin B。其中3-乙酰毛萼结晶S为新的对映-贝壳杉烷型二萜。由波谱法确定其结构。     

毛萼鞘蕊花甲素的结构

从毛萼鞘蕊花(Coleus esquirolii(L(?)vl. )Dunn.)的茎、叶中分离鉴定了一个新的二萜化合物,毛萼鞘蕊花甲素(对映-17-乙酰氧基-贝壳杉烷-16β-醇),和三个已知化合物,对映-贝壳杉烷-16p,17-二醇,齐墩果酸和β-谷甾醇。     

斜脉暗罗素甲—具有C5—OH的单四氢呋喃环型番荔枝内酯

从斜脉暗罗（Ｐｏｌｙａｌｔｈｉａ ｐｌａｇｉｏｎｅｕｒａ Ｄｉｅｌｓ）的种子中分离到化合物Ｐ４ 及Ｐ５,经ＩＲ、１Ｈ－ＮＭＲ、１３ Ｃ－ＮＭＲ及ＭＳ谱鉴定,Ｐ４ 为海南哥纳香甲素,Ｐ５ 为具有Ｃ５－ＯＨ 的单四氢呋喃环型番荔枝内酯,命名为斜脉暗罗素甲（ｐｌａｇｉｏｎｉｃｉｎ Ａ）。     

Cytotoxic ent-kaurane diterpenoids from Isodon eriocalyx

Five new ent-kaurane diterpenoids, epi-maoecrystal N (1), eriocalyxin G (2), maoecrystal W (3), maoecrystal X (4), and maoecrystal Y (5), along with 22 known ones, were isolated from Isodon eriocalyx (Dunn.) Hara., and their structures were determined by spectroscopic methods. All diterpenoids, except for 3 and 13, were evaluated for inhibition of the K562, T-24, Me180, QGY-7701, and BIU87 cell lines (Table 2).     

锦鸡儿属种系发生关系重建的探讨

基于形态学、染色体、花粉形态24个特征,采用分支系统学方法研究锦鸡儿属（Caragana）的种系发生关系。根据分支图结果,将锦鸡儿属72种排列成12系5组。分支图也表达出分类群演化关系,对Moore(1968)种系发生方案提出了修改,重建了本属的种系发生关系。     

ent-Kaurene diterpenoids from Isodon oresbius

Three new ent-kaurene diterpenoids, oreskaurins A-C (1-3), together with ten known ent-kaurene diterpenoids, enmenin monoacetate (4), effusanin E (5), adenolin B (6), maoecrystal G (7), enmelol (8), trichokaurin (9), sodoponin (10), trichorabdal A (11), nodosin (12), enmein (13), and a flavonoid, vitexin (14), were isolated from Isodon oresbius. Their structures were determined by spectroscopic means. Compound 12 showed inhibitory activity toward K562 cells with IC(50)=1.43 microg/ml.     

Adenosine A1 and A2A receptor regulation of protein phosphatase 2A in the murine heart

Adenosine plays a role in regulating the contractile function of the heart. This includes a positive ionotropic action via the adenosine A(2A) receptor (A(2A)R) and an inhibition of beta(1)-adrenergic receptor-induced ionotropy (antiadrenergic action) via the adenosine A(1) receptor (A(1)R). Phosphatase activity has also been shown to influence contractile function by affecting the level of protein phosphorylation. Protein phosphatase 2A (PP2A) plays a significant role in mediating the A(1)R antiadrenergic effect. The purpose of this study was to investigate the effects of A(2A)R and A(1)R on the activities of PP2A in hearts obtained from wild-type (WT) and A(2A)R knockout (A(2A)R-KO) mice. PP2A activities were examined in myocardial particulate and cytoplasmic extract fractions. Treatment of wild-type hearts with the A(1)R agonist CCPA increased the total PP2A activity and increased the particulate:cytoplasmic PP2A activity ratio. Treatment with the A(2A)R agonist CGS-21680 (CGS) decreased the total PP2A activity and decreased the particulate:cytoplasmic PP2A activity ratio. This indicated a movement of PP2A activity between cell fractions. The effect of CCPA was inhibited by CGS. In A(2A)R-KO hearts the response to A(1)R activation was markedly enhanced whereas the response to A(2A)R activation was absent. These data show that A(2A)R and A(1)R regulate PP2A activity, thus suggesting an important mechanism for modulating myocardial contractility.     

In rat hepatocytes, different adenosine receptor subtypes use different secondary messengers to increase the rate of ureagenesis

In rat hepatocytes, the role of cAMP and Ca(2+) as secondary messengers in the ureagenic response to stimulation of specific adenosine receptor subtypes was explored. Analyzed receptor subtypes were: A(1), A(2A), A(2B) and A(3). Each receptor subtype was stimulated with a specific agonist while blocking all other receptor subtypes with a battery of specific antagonists. For the A(1) and A(3) adenosine receptor subtypes, the secondary messenger was the cytoplasmic Ca(2+) concentration ([Ca(2+)](cyt)). Accordingly, the A(1) or A(3)-mediated increase in [Ca(2+)](cyt) and in ureagenic activity were both inhibited by chelating Ca(2+) with either EGTA or BAPTA-AM. Also, Gd(3+) blocked both the increase in [Ca(2+)](cyt) and ureagenesis, suggesting that a Ca(2+) channel may be involved in the response to both A(1) and A(3). A partial effect was observed with the sarcoplasmic reticulum Ca(2+)-ATPase inhibitor thapsigargin. The concentration of cyclic AMP ([cAMP]) increased in response to stimulation of either the A(2A) or the A(2B) adenosine receptor subtypes, while it decreased slightly in response to stimulation of either A(1) or A(3). The stimulation of either the A(2A) or A(2B) adenosine receptor subtypes resulted in an increase in [cAMP] and an ureagenic response which were not sensitive to EGTA, BAPTA-AM, Gd(3+) or to thapsigargin. In addition, the adenylyl cyclase inhibitor MDL12,330A blocked the ureagenic response to A(2A) and A(2B), but not the response to either A(1) or A(3). Our results indicate that in the ureagenic liver response to adenosine, the secondary messenger for both, the A(1) and A(3) adenosine receptor subtypes is [Ca(2+)](cyt), while the message from the A(2A) and A(2B) adenosine receptor subtypes is relayed by [cAMP].     

Oligomerization of adenosine A2A and dopamine D2 receptors in living cells

We investigated whether oligomerization of adenosine A(2A) receptor (A(2A)R) and dopamine D(2) receptor (D(2)R) exists in living cells using modified bioluminescence resonance energy transfer (BRET(2)) technology. Fusion of these receptors to a donor, Renilla luciferase (Rluc), and to an acceptor, modified green fluorescent protein (GFP(2)), did not affect the ligand binding affinity, subcellular distribution, and coimmunoprecipitation of the receptors. BRET was detected not only between Myc-D(2)R-Rluc and A(2A)R-GFP(2) but also between HA-tagged A(2A)R-Rluc and A(2A)R-GFP(2). These results indicate A(2A)R, either homomeric or heteromeric with D(2)R, exists as an oligomer in living cells.     

Molecular species of glycinin in some soybean cultivars

A(4) polypeptide-containing (Shirotsurunoko and York) and A(4) polypeptide-lacking (Raiden and Suzuyutaka) soybean cultivars were used to investigate the heterogeneity of glycinin molecular species. Purification of glycinin by DEAE-Toyopearl column chromatography afforded molecular species eluting before the glycinin fraction. Analysis of this fraction by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) and sucrose density gradient centrifugation indicated that this protein consisted of A(1) and A(2) polypeptides. The A(4)-containing soybean cultivars contained less of this protein than the A(4)-lacking soybean cultivars, as exhibited by the size of the early peak appearing during column chromatography. Alkaline PAGE and N-terminal amino acid sequence analysis confirmed that the A(1)- and A(2)-rich molecular species in the A(4) polypeptide-lacking cultivars consisted of the A(1a) and A(2) polypeptides. Estimation of the molecular mass by gel permeation chromatography and multi-angle laser light scattering (GPC-MALLS) indicated that the A(1a)- and A(2)-rich molecular species were similar to a monomer of glycinin.     

Selective inactivation or reconstitution of adenosine A2A receptors in bone marrow cells reveals their significant contribution to the development of ischemic brain injury

Inactivation of the adenosine A(2A) receptor (A(2A)R) consistently protects against ischemic brain injury and other neural insults, but the relative contribution of A(2A)Rs on peripheral inflammatory cells versus A(2A)Rs expressed on neurons and glia is unknown. We created a chimeric mouse model in which A(2A)Rs on bone marrow-derived cells (BMDCs) were selectively inactivated or reconstituted by bone marrow transplantation. Selective reconstitution of A(2A)Rs on BMDCs (A(2A)R knockout mice transplanted with wild-type bone marrow cells) largely reinstates ischemic brain injury in global A(2A)R knockout mice. Conversely, selective inactivation of A(2A)Rs on BMDCs (wild-type mice transplanted with A(2A)R knockout bone marrow cells) attenuates infarct volumes and ischemia-induced expression of several proinflammatory cytokines in the brain, but exacerbates ischemic liver injury. These results indicate that the A(2A)R-stimulated cascade in BMDCs is an important modulator of ischemic brain injury and that ischemic brain and liver injuries are regulated distinctly by A(2A)Rs on BMDCs.     

Adenosine receptor-mediated modulation of dopamine release in the nucleus accumbens depends on glutamate neurotransmission and N-methyl-D-aspartate receptor stimulation

Adenosine, by acting on adenosine A(1) and A(2A) receptors, exerts opposite modulatory roles on striatal extracellular levels of glutamate and dopamine, with activation of A(1) inhibiting and activation of A(2A) receptors stimulating glutamate and dopamine release. Adenosine-mediated modulation of striatal dopaminergic neurotransmission could be secondary to changes in glutamate neurotransmission, in view of evidence for a preferential colocalization of A(1) and A(2A) receptors in glutamatergic nerve terminals. By using in vivo microdialysis techniques, local perfusion of NMDA (3, 10 microm), the selective A(2A) receptor agonist 2-p-(2-carboxyethyl)phenethylamino-5'-N-ethylcarboxamidoadenosine (CGS 21680; 3, 10 microm), the selective A(1) receptor antagonist 8-cyclopentyl-1,3-dimethylxanthine (CPT; 300, 1000 microm), or the non-selective A(1)-A(2A) receptor antagonist in vitro caffeine (300, 1000 microm) elicited significant increases in extracellular levels of dopamine in the shell of the nucleus accumbens (NAc). Significant glutamate release was also observed with local perfusion of CGS 21680, CPT and caffeine, but not NMDA. Co-perfusion with the competitive NMDA receptor antagonist dl-2-amino-5-phosphonovaleric acid (APV; 100 microm) counteracted dopamine release induced by NMDA, CGS 21680, CPT and caffeine. Co-perfusion with the selective A(2A) receptor antagonist MSX-3 (1 microm) counteracted dopamine and glutamate release induced by CGS 21680, CPT and caffeine and did not modify dopamine release induced by NMDA. These results indicate that modulation of dopamine release in the shell of the NAc by A(1) and A(2A) receptors is mostly secondary to their opposite modulatory role on glutamatergic neurotransmission and depends on stimulation of NMDA receptors. Furthermore, these results underscore the role of A(1) vs. A(2A) receptor antagonism in the central effects of caffeine.